Neoantigen-based immunotherapy in solid tumors
China National GeneBank DataBase · 01.01.2024
DOI: 10.26036/cnp0000871 ↗Kurz gefasst
Fachartikel in der Zeitschrift China National GeneBank DataBase, erschienen am 01.01.2024. Verfasst von Chao Chen.
Abstract (Originalsprache)
The purpose of this study is to characterize the genomic background of solid tumors and develop neoantigen-based immunotherapy. First, next-generation sequencing was performed on tumor tissues and corresponding peripheral blood of cancer patients. Second, bioinformatics analysis, including HLA typing, mutation detection, identification of tumor-specific antigens (neoantigens) was performed. Then, neoantigen-based cell therapy, such as neoantigen activated cytotoxic T lymphocytes (CTLs), neoantigen-loaded dendritic cells (DCs) were generated for immunotherapy.
Schlagwörter
Zitieren
APA
Chen, C. (2024). Neoantigen-based immunotherapy in solid tumors. China National GeneBank DataBase. https://doi.org/10.26036/cnp0000871
Vancouver
Chen C. Neoantigen-based immunotherapy in solid tumors. China National GeneBank DataBase. 2024. doi:10.26036/cnp0000871
BibTeX
@article{Chen2024,
author = {Chen, Chao},
title = {Neoantigen-based immunotherapy in solid tumors},
journal = {China National GeneBank DataBase},
year = {2024},
doi = {10.26036/cnp0000871}
}
EUVIMED